"skipMainNavigation"
Search
Quick Search in Journals
Quick Search anywhere
Advanced Search
Radiology
Menu
Previous
Next
Original Research

Prostate Cancer: Detection of Lymph Node Metastases Outside the Routine Surgical Area with Ferumoxtran-10–enhanced MR Imaging

Published Online:May 1 2009https://doi.org/10.1148/radiol.2512071018

Abstract

Purpose: To prospectively evaluate the feasibility of magnetic resonance (MR) imaging with ferumoxtran-10 in patients with prostate cancer to depict lymph node metastases outside the routine pelvic lymph node dissection (PLND) area.

Materials and Methods: The study was approved by the institutional review boards at all four hospitals; patients provided written informed consent. Two hundred ninety-six consecutive men (mean age, 67 years; range, 47–83 years) with prostate cancer and an intermediate-to-high risk for nodal metastases (prostate-specific antigen level >10 ng/mL, Gleason score >6, or stage T3 disease) were enrolled. MR lymphography of the pelvis was performed 24 hours after intravenous drip infusion of ferumoxtran-10. Positive nodes at MR lymphography were indicated to be inside or outside the routine dissection area (RDA). On the basis of MR lymphography computed tomographic (CT)–guided biopsy, routine PLND, or MR imaging–guided minimal extended PLND was performed.

Results: MR lymphography findings were positive in 58 patients. Of these, 44 had histopathologic confirmation of lymph node metastases. In 18 of 44 patients (41%), MR lymphography findings showed nodes exclusively outside the RDA, which were confirmed with MR lymphography–guided extended PLND (n = 13) and CT-guided biopsy (n = 5). In another 18 patients (41%), positive nodes were located both inside and outside the RDA at MR lymphography. In these 18 patients, routine PLND was used to confirm the nodes inside the RDA (n = 11); CT-guided biopsy was used to confirm nodes outside the RDA (n = 7). In the remaining eight patients, MR lymphography findings showed only nodes inside the RDA, which was confirmed with PLND (n = 5) and CT-guided biopsy (n = 3). In 14 of the 58 patients (24%), there was no histologic confirmation.

Conclusion: In 41% of patients with prostate cancer, nodal metastases outside the area of routine PLND were detected by using MR imaging with ferumoxtran-10.

© RSNA, 2009

References

  • 1 Borley N, Fabrin K, Sriprasad S, et al. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in “high-risk” prostate cancer compared to MRI or CT. Scand J Urol Nephrol 2003; 37: 382–386.
    Medline Google Scholar
  • 2 Flanigan RC, McKay TC, Olson M, Shankey TV, Pyle J, Waters WB. Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 1996; 48: 428–432.
    Medline Google Scholar
  • 3 Hricak H, Dooms GC, Jeffrey RB, et al. Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. Radiology 1987; 162: 331–336.
    Google Scholar
  • 4 Burkhard FC, Studer UE. The role of lymphadenectomy in prostate cancer. Urol Oncol 2004; 22: 198–202.
    Medline Google Scholar
  • 5 Heidenreich A, Varga Z, von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002; 167: 1681–1686.
    Medline Google Scholar
  • 6 McDowell GC, Johnson JW, Tenney DM, Johnson DE. Pelvic lymphadenectomy for staging clinically localized prostate cancer: indications, complications, and results in 217 cases. Urology 1990; 35: 476–482.
    Medline Google Scholar
  • 7 Schuessler WW, Pharand D, Vancaillie TG. Laparoscopic standard pelvic node dissection for carcinoma of the prostate: is it accurate? J Urol 1993; 150: 898–901.
    Medline Google Scholar
  • 8 Stone NN, Stock RG, Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol 1997; 158: 1891–1894.
    Medline Google Scholar
  • 9 Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004; 172: 1840–1844.
    Medline Google Scholar
  • 10 Jeschke S, Nambirajan T, Leeb K, Ziegerhofer J, Sega W, Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2005; 173: 1943–1946.
    Medline Google Scholar
  • 11 Brenot-Rossi I, Bastide C, Garcia S, et al. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 2005; 32: 635–640.
    Medline Google Scholar
  • 12 Finelli A, Gill IS, Desai MM, Moinzadeh A, Magi-Galluzzi C, Kaouk JH. Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. J Urol 2004; 172: 1809–1812.
    Medline Google Scholar
  • 13 Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol 1996; 167: 1503–1507.
    Medline Google Scholar
  • 14 Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491–2499.
    Medline Google Scholar
  • 15 Deserno WM, Harisinghani MG, Taupitz M, et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 2004; 233: 449–456.
    Google Scholar
  • 16 Heesakkers RA, Barentsz JO, Deserno W, Witjes F, Hulsbergen-van der Kaa C. Criteria for evaluating lymph nodes with USPIO enhanced MRI [abstr]. Eur Radiol 2003; 13: 539.
    Google Scholar
  • 17 Raghavaiah NV, Jordan WP Jr. Prostatic lymphography. J Urol 1979; 121: 178–181.
    Medline Google Scholar
  • 18 Clark T, Parekh DJ, Cookson MS, et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003; 169: 145–147.
    Medline Google Scholar
  • 19 Brendler CB, Cleeve LK, Anderson EE, Paulson DF. Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol 1980; 124: 849–850.
    Medline Google Scholar
  • 20 Daneshmand S, Quek ML, Stein JP, et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 2004; 172: 2252–2255.
    Medline Google Scholar
  • 21 Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy: is there a chance of cure? J Urol 2003; 169: 849–854.
    Medline Google Scholar

Article History

Published in print: 2009